High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$11.3M
$11,340,633
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-04-01 | $29,196 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$195,703
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $195,703 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$141,328
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $141,328 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$68,917
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $68,917 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$248,767
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $248,767 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$260,038
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $260,038 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-04-01
$91,471
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-04-01 | $91,471 | S | Form 4 |
|
LGND
M
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
Other
2026-04-01
$261,350
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
Other
|
2026-04-01 | $261,350 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-04-01 | $32,478 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-04-01 | $8,725 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-04-01 | $15,991 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-04-01 | $8,049 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2026-03-23 | $207,873 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -12.7%
|
2026-03-11 | $687,825 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-11 | $222,823 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
LAMATTINA JOHN L
• Director
Discretionary Sell
2026-03-06
$433,842
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2026-03-06 | $433,842 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2026-03-06 | $246,678 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $299,841 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$238,532
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $238,532 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$300,939
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $300,939 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$126,689
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $126,689 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$70,165
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $70,165 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$94,382
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $94,382 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$40,834
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $40,834 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$60,510
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $60,510 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$18,658
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $18,658 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$41,391
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $41,391 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$19,900
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $19,900 | S | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
10b5-1 Sell
2026-03-04
$19,770
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
10b5-1 Sell
|
2026-03-04 | $19,770 | S | Form 4 |
|
LGND
M
LIGAND PHARMACEUTICALS INC
Reardon Andrew
• Officer • CLO & Secretary
Other
2026-03-04
$261,350
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Officer • CLO & Secretary
Other
|
2026-03-04 | $261,350 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -13.6%
|
2026-03-04 | $712,621 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $510,823 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $328,542 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-04 | $37,616 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-04 | $93,993 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $152,125 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $136,024 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $141,343 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $191,640 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $140,364 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $10,604 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-04 | $138,895 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $141,383 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2026-03-03 | $409,851 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $16,737 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $9,266 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $40,737 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $8,217 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $10,127 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-02 | $8,550 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-02 | $7,449 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-02 | $4,535 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-02 | $74,814 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-02 | $4,499 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-02 | $192 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $18,719 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $63,091 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $3,948 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $18,132 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Other
|
2025-12-16 | $60,408 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2025-12-12 | $339,711 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Equity Compensation
|
2025-12-08 | $0 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2025-12-08 | $141,383 | M | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $6,000 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $4,582 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $18,190 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $17,835 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $34,862 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $9,203 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-12-01 | $785 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2025-11-07 | $235,372 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
LAMATTINA JOHN L
• Director
Discretionary Sell
2025-11-07
$417,885
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-11-07 | $417,885 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2025-11-07 | $141,383 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
LAMATTINA JOHN L
• Director
Discretionary Sell
2025-11-07
$440,690
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-11-07 | $440,690 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2025-11-07 | $141,849 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Gray Nancy Ryan
• Director
Discretionary SellΔOwn -30.5%
2025-11-07
$730,580
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary SellΔOwn -30.5%
|
2025-11-07 | $730,580 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Other
|
2025-11-07 | $221,814 | M | Form 4 |
|
LGND
S
LIGAND PHARMACEUTICALS INC
Gray Nancy Ryan
• Director
Discretionary SellΔOwn -27.1%
2025-11-07
$619,432
|
||||||
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary SellΔOwn -27.1%
|
2025-11-07 | $619,432 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-11-03 | $24,432 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-11-03 | $15,876 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-11-03 | $9,323 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-11-03 | $39,589 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-01 | $4,263 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-01 | $34,967 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-01 | $27,902 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2025-10-01 | $16,669 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-09-23 | $752,850 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-09-23 | $791,223 | S | Form 4 |
| LGND |
LIGAND PHARMACEUTICALS INC
|
Director
Discretionary Sell
|
2025-09-23 | $164,015 | S | Form 4 |